A new turmeric compound kills myeloma cells

A brand new study shows that another turmeric compound, which I shall refer to by its acronym, SQP (much easier to remember than “beta-sesquiphellandrene”! 😉 ), has the same anticancer potential of curcumin: http://goo.gl/e2jBGe

turmericSQP kills human multiple myeloma, leukemia, and colorectal cancer cells, in a similar manner to curcumin. It also works in synergy with bortezomib (Velcade), thalidomide, and capecitabine.

Now, I haven’t read the full study yet, but if I can get my hands on it, I will certainly see if I can dig out a few more helpful and/or interesting details.

Of course, before getting all excited about this new compound, we should keep in mind that it could take some (a lot of?) time to transform it into something useful–a pill, e.g. Besides, as of now, we don’t know anything about its bioavailability, blablabla. So it’s really early in the game.

Still, I always find it exciting to read about another multiple myeloma killer… 🙂

5 Comments

  1. A little too late for my wife who passed 2 1/2 years ago with myeloma. Crazy thing did happen though. She was on thalidomide and velcade when I found 1000 mg turmeric capsule for her. She was one to check in with her doctor before taking it and he said fine. Two weeks go by and her test for light chains had been reduced in half. They were always around 2200 for the first year and a half. The doctor was so surprised he himself called her at 830 in the evening to deliver the news.

    Now what happens afterwards is my wife quit taking it, for whatever reason. It was difficult to talk about but her words were along the lines of “yet another pill to consume.” I think she was simply getting tired of being a lab rat and gave up. Either that or God wanted her.

  2. I love your blog! I’ve been following it for nearly 7 years after my diagnosis with MGUS. Reading everything I can get my hands on about this crazy malady. Thanks so much for your researching the research! Blessings.

Leave a Reply

Your email address will not be published. Required fields are marked *